Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Brain, Behavior, and Immunity|October 20, 2010
Immune suppression and immune activation in depressionJoshua Blume, Steven D Douglas, Dwight L Evans
CNS Spectrums|May 27, 2003
Substance P and Human Immunodeficiency Virus Infection: PsychoneuroimmunologyWen-Zhe Ho, Dwight L Evans, Steven D Douglas
The Journal of Neuropsychiatry and Clinical Neurosciences|March 15, 2013
The glucocorticoid antagonist RU-486 suppresses HIV infectivity and replicationTami D Benton, Kevin G Lynch, Benoit Dubé, et al.
Psychosomatic Medicine|October 16, 2010
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replicationTami Benton, Kevin Lynch, Benoit Dubé, et al.
Trends in Immunology|May 12, 2009
Neurokinin 1 receptor isoforms and the control of innate immunityFlorin Tuluc, Jian Ping Lai, Laurie E Kilpatrick, et al.
Medicine|June 11, 2021
Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIVSergei Spitsin, Vasiliki Pappa, Annemarie Kinder, et al.
Biological Psychiatry|August 2, 2003
Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV diseaseDean G Cruess, Dwight L Evans, Martin J Repetto, et al.
CNS Spectrums|March 11, 2003
Neuropsychopharmacologic treatment of depression and other neuropsychiatric disorders in HIV-infected individualsMartin J Repetto, Dwight L Evans, Dean G Cruess, et al.
AIDS Research and Human Retroviruses|March 11, 2008
Elevated substance P levels in HIV-infected women in comparison to HIV-negative womenSteven D Douglas, Avital Cnaan, Kevin G Lynch, et al.
JCI Insight|October 6, 2017
Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adultsSergei Spitsin, Pablo Tebas, Jeffrey S Barrett, et al.
Pageof 15